TransCode Therapeutics Advances Innovative Cancer Treatments
TransCode Therapeutics Advances Innovative Cancer Treatments TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has recently received exciting news regarding its clinical trial aimed at developing effective therapies for cancer. The Safety Review Committee has officially green-lighted the opening of the fourth cohort in their Phase I clinical trial, reflecting the company’s...
Continue Reading